Panacea Life Sciences Holdings annual asset turnover
2015
2016
2017
2018
2019
2020
2021
2022
2023
Panacea Life Sciences Holdings Asset Turnover Growth & History (PLSH)
Panacea Life Sciences Holdings's asset turnover was 0.13 for fiscal 2023.
View full Panacea Life Sciences Holdings company overviewPanacea Life Sciences Holdings annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | 0.13 | 0.05 | +69.28% |
| 2022 | 2022-12-31 | 0.08 | 0.00 | +0.67% |
| 2021 | 2021-12-31 | 0.07 | −0.38 | −83.69% |
| 2020 | 2020-12-31 | 0.46 | 0.37 | +432.03% |
| 2019 | 2019-12-31 | 0.09 | 0.09 | — |
| 2018 | 2018-12-31 | 0.00 | 0.00 | — |
| 2017 | 2017-12-31 | 0.00 | 0.00 | — |
| 2016 | 2016-12-31 | 0.00 | −0.00 | — |
| 2015 | 2015-12-31 | 0.00 | — | — |
Panacea Life Sciences Holdings quarterly asset turnover
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q1 2024 | 2024-03-31 | 0.15 | 0.06 | +71.27% |
| Q4 2023 | 2023-12-31 | 0.13 | 0.05 | +69.28% |
| Q3 2023 | 2023-09-30 | 0.09 | −0.02 | −18.91% |
| Q2 2023 | 2023-06-30 | 0.09 | −0.02 | −19.32% |
| Q1 2023 | 2023-03-31 | 0.09 | −0.14 | −60.10% |
| Q4 2022 | 2022-12-31 | 0.08 | 0.00 | +0.67% |
| Q3 2022 | 2022-09-30 | 0.11 | −0.00 | −3.69% |
| Q2 2022 | 2022-06-30 | 0.11 | −0.03 | −22.65% |
| Q1 2022 | 2022-03-31 | 0.22 | −2.18 | −90.64% |
| Q4 2021 | 2021-12-31 | 0.07 | −0.38 | −83.69% |
| Q3 2021 | 2021-09-30 | 0.12 | −1.22 | −91.37% |
| Q2 2021 | 2021-06-30 | 0.14 | −1.02 | −87.74% |
| Q1 2021 | 2021-03-31 | 2.40 | 2.22 | +1202.79% |
| Q4 2020 | 2020-12-31 | 0.46 | 0.37 | +432.03% |
| Q3 2020 | 2020-09-30 | 1.34 | 1.30 | +3572.43% |
| Q2 2020 | 2020-06-30 | 1.16 | 1.13 | +3179.43% |
| Q1 2020 | 2020-03-31 | 0.18 | 0.18 | +3347.52% |
| Q4 2019 | 2019-12-31 | 0.09 | 0.09 | — |
| Q3 2019 | 2019-09-30 | 0.04 | 0.04 | — |
| Q2 2019 | 2019-06-30 | 0.04 | 0.04 | — |
| Q1 2019 | 2019-03-31 | 0.01 | 0.01 | — |
| Q4 2018 | 2018-12-31 | 0.00 | 0.00 | — |
| Q3 2018 | 2018-09-30 | 0.00 | 0.00 | — |
| Q2 2018 | 2018-06-30 | 0.00 | 0.00 | — |
| Q1 2018 | 2018-03-31 | 0.00 | 0.00 | — |
| Q4 2017 | 2017-12-31 | 0.00 | 0.00 | — |
| Q3 2017 | 2017-09-30 | 0.00 | −0.00 | — |
| Q2 2017 | 2017-06-30 | 0.00 | −0.00 | — |
| Q1 2017 | 2017-03-31 | 0.00 | −0.00 | — |
| Q4 2016 | 2016-12-31 | 0.00 | — | — |
| Q3 2016 | 2016-09-30 | 0.00 | — | — |
| Q2 2016 | 2016-06-30 | 0.00 | — | — |
| Q1 2016 | 2016-03-31 | 0.00 | — | — |
Panacea Life Sciences Holdings asset turnover trends
Over the last five fiscal years, Panacea Life Sciences Holdings's asset turnover increased from 0.00 to 0.13, a change of 0.13. The latest reported quarter, Q1 2024, shows 0.15.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Panacea Life Sciences Holdings source filings ↗